Portside Wealth Group’s DexCom DXCM Stock Holding History

Portside Wealth Group’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,602	Closed	-$402K	–	491
2025 Q2	$402K	Buy	4,602 +376	+9%	+$29.5K	0.06%	281
2025 Q1	$289K	Buy	4,226 +80	+2%	+$6.53K	0.05%	346
2024 Q4	$322K	Buy	+4,146	New	+$307K	0.05%	312

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Portside Wealth Group's DXCM Position: Q3 2025 in Review

Portside Wealth Group sold out of DexCom (DXCM) in Q3 2025, closing a stake of 4,602 shares — an estimated $402K sold.

Portside Wealth Group first reported a position in DXCM in Q4 2024 and held it in 3 quarters. The position peaked at $402K in Q2 2025. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

Portside Wealth Group reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
Portside Wealth Group sold 4,602 DexCom shares in Q3 2025, an estimated $402K.
Portside Wealth Group first reported a position in DexCom in Q4 2024 and held it in 3 quarters.
Portside Wealth Group's DexCom position peaked at $402K in Q2 2025.
911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Portside Wealth Group's 13F filing for Q3 2025, filed 5 Nov 2025.